Alvotech (ALVO)
12.44
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
12.40
-0.04
(-0.32%)
After-Hours: 20:00
Alvotech Total Liabilities (Quarterly): 1.577B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.577B |
| June 30, 2024 | 1.674B |
| March 31, 2024 | 1.719B |
| December 31, 2023 | 1.883B |
| September 30, 2023 | 1.620B |
| June 30, 2023 | 1.389B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.551B |
| December 31, 2022 | 1.393B |
| September 30, 2022 | 960.36M |
| June 30, 2022 | 1.071B |
| December 31, 2021 | 733.59M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
733.59M
Minimum
Dec 2021
1.883B
Maximum
Dec 2023
1.416B
Average
1.551B
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Procaps Group SA | 460.10M |
| Johnson & Johnson | 108.13B |
| Pfizer Inc | 126.92B |
| Rigel Pharmaceuticals Inc | 154.06M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.233B |
| Shareholders Equity (Quarterly) | -343.71M |
| Debt to Equity Ratio | -2.991 |
| Current Ratio | 2.694 |
| Net Debt Paydown Yield | -1.22% |